Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sotera Health CoSHC -0.77%77 Equity-to-Asset is 0.19 as of Mar. 2026, which is 27% above its 10-year median of 0.15. GuruFocus rates SHC with a GF Score™ of 77/100 and a GF Value™ of $16.40 (Fairly Valued). The stock has 5 warning signs investors should review. Among 211 Medical Diagnostics & Research companies, Sotera Health Co ranks worse than 87.2% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Sotera Health Co's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $623 Mil. Sotera Health Co's Total Assets for the quarter that ended in Mar. 2026 was $3,236 Mil.
Therefore, Sotera Health Co's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.19.
The historical rank and industry rank for Sotera Health Co's Equity-to-Asset or its related term are showing as below:
SHC'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.27 Med: 0.15 Max: 0.23
Current: 0.19
During the past 8 years, the highest Equity to Asset Ratio of Sotera Health Co was 0.23. The lowest was -0.27. And the median was 0.15.
SHC's Equity-to-Asset is ranked worse than 87.2% of 211
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.59
vs SHC: 0.19
Sotera Health Co (NAS:SHC) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Sotera Health Co Equity-to-Asset Related Terms
Sotera Health Co Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Sotera Health Co's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHC vs RDNT, VCYT, TWST: Equity-to-Asset Comparison
For the Diagnostics & Research subindustry, Sotera Health Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sotera Health Co Equity-to-Asset vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Sotera Health Co's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Sotera Health Co's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Sotera Health Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sotera Health Co (SHC) has a Equity-to-Asset of 0.19 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Sotera Health Co and its competitors. This is 27% above median its historical median of 0.15. According to the industry distribution chart, Sotera Health Co ranks #184 out of 211 companies in the Medical Diagnostics & Research industry, placing it in the top 87.2%.
Is Sotera Health Co's Equity-to-Asset too high?
Sotera Health Co's current Equity-to-Asset of 0.19 is 27% above median its 10-year median of 0.15. The Medical Diagnostics & Research industry median Equity-to-Asset is 0.59. Sotera Health Co's value of 0.19 is 67.8% below this industry median. Based on the distribution chart, Sotera Health Co ranks #184 out of 211 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Sotera Health Co has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sotera Health Co's Equity-to-Asset compare to RDNT and VCYT?
According to the Medical Diagnostics & Research industry distribution chart, Sotera Health Co ranks #184 out of 211 companies for Equity-to-Asset. This places Sotera Health Co in the lower half of its industry. The industry median Equity-to-Asset is 0.59. Sotera Health Co's value of 0.19 is 67.8% below this benchmark. While the company's 10-year median is 0.15 vs. the industry median of 0.59, Sotera Health Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Diagnostics & Research company?
The median Equity-to-Asset among Medical Diagnostics & Research companies is 0.59, based on 211 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sotera Health Co's current Equity-to-Asset of 0.19 is 67.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Sotera Health Co and its competitors. For the Medical Diagnostics & Research industry, the median Equity-to-Asset is 0.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sotera Health Co's current Equity-to-Asset is 0.19, which is 27% above median its own 10-year median of 0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sotera Health Co stock overvalued right now?
Based on GuruFocus' analysis, Sotera Health Co (SHC) is currently considered Fairly Valued. The stock's GF Value™ is $16.40, compared to a current price of $17.98 — trading 9.6% above its estimated fair value. The current Equity-to-Asset is 0.19, which is 27% above median its 10-year median of 0.15 and 67.8% below the Medical Diagnostics & Research industry median of 0.59. Sotera Health Co's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Sotera Health Co (SHC), the current Equity-to-Asset is 0.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sotera Health Co (SHC) Overvalued in 2026?
Based on GuruFocus' analysis, Sotera Health Co stock appears to be overvalued.
The current stock price of $17.98 is trading 9.6% above its estimated GF Value™ of $16.40.
GuruFocus considers Sotera Health Co to be Fairly Valued.
Key valuation signals for SHC:
Equity-to-Asset: 0.19 (27% above median its 10-year median of 0.15)
GF Value™: $16.40 vs. price of $17.98 (9.6% above fair value)
Industry Position: 67.8% below the Medical Diagnostics & Research median (#184 of 211)
No single metric tells the full story. See the SHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
77GF Score
Get the complete analysis for SHC
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHC has been successfully added to your 
